Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
134
NCT01744808
A Study to Evaluate the Safety, Tolerance, and Pharmacokinetic and Pharmacodynamic Profile Of 1 SR Formulation of EB-1020
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 28, 2013
Completion: Feb 28, 2014
NCT02144415
A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users
Start: May 31, 2014
Completion: Jul 31, 2014